Bezafibrate

Effects and efficacy:
Bezofibrate is used to treat primary hyperlipidemia and secondary hyperlipidemia that cannot be improved after treatment of major diseases (such as diabetes, etc.). It is mainly used for IIa, IIb and IV hyperlipidemia.
Usage and dosage:
The main usage of bezafibrate is oral administration, which can be taken after meals or with meals. The usual dose for adults is 3 times a day, 0.2~0.4g each time. The maintenance dose for patients with good efficacy can be 2 times a day, 0.4g each time. In case of renal dysfunction, the dose is adjusted according to the creatinine clearance rate: 40~60ml/min, 2 times a day, 0.4g each time; 15~40ml/min, 1 time a day or every other day, 0.4g each time; less than 15ml/min, 1 time every 3 days, 0.4g each time. It can be taken after meals or with meals.
Drug contraindications:
Allergy to this product is prohibited. It is prohibited during pregnancy. It is prohibited during lactation. It is prohibited for children with hepatic and renal insufficiency.
Related dosage forms:
Tablets, capsules